Silence Therapeutics
SLN
#5861
Rank
NZ$2.19 B
Marketcap
NZ$35.22
Share price
0.05%
Change (1 day)
204.89%
Change (1 year)

EPS for Silence Therapeutics (SLN)

EPS in 2026 (TTM): NZ-$2.76

According to Silence Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$2.89. In 2025 the company made an earnings per share (EPS) of NZ-$3.37 a decrease over its 2024 EPS that were of NZ-$1.76.

EPS history for Silence Therapeutics from 1996 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$2.76-18.03%
2025NZ-$3.3790.91%
2024NZ-$1.76-32.65%
2023NZ-$2.62-5.77%
2022NZ-$2.78-13.03%
2021NZ-$3.2010.23%
2020NZ-$2.9058.5%
2019NZ-$1.832.94%
2018NZ-$1.78969.59%
2017NZ-$0.17-79.18%
2016NZ-$0.80-3.11%
2015NZ-$0.82-55%
2014NZ-$1.833.83%
2013NZ-$1.76-84.88%
2012NZ-$11.66134.19%
2011NZ-$4.98-61.8%
2010NZ-$13.04-45.65%
2009NZ-$23.99-1.16%
2008NZ-$24.274.29%
2007NZ-$23.2710.54%
2006NZ-$21.05-22.29%
2005NZ-$27.09-57.32%
2004NZ-$63.4839.1%
2003NZ-$45.6470.67%
2002NZ-$26.74-25.17%
2001NZ-$35.745.29%
2000NZ-$33.94-24.54%
1999NZ-$44.9826.7%
1998NZ-$35.50-11.73%
1997NZ-$40.2272.24%
1996NZ-$23.35